DK1343766T3 - Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner - Google Patents
Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridinerInfo
- Publication number
- DK1343766T3 DK1343766T3 DK01990192T DK01990192T DK1343766T3 DK 1343766 T3 DK1343766 T3 DK 1343766T3 DK 01990192 T DK01990192 T DK 01990192T DK 01990192 T DK01990192 T DK 01990192T DK 1343766 T3 DK1343766 T3 DK 1343766T3
- Authority
- DK
- Denmark
- Prior art keywords
- naphthyridines
- quinolones
- cyclization
- preparation
- process step
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25563300P | 2000-12-14 | 2000-12-14 | |
PCT/US2001/048536 WO2002048113A1 (en) | 2000-12-14 | 2001-12-07 | Cyclization process step in the making of quinolones and naphthyridines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1343766T3 true DK1343766T3 (da) | 2005-10-31 |
Family
ID=22969207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01990192T DK1343766T3 (da) | 2000-12-14 | 2001-12-07 | Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1343766B1 (es) |
JP (2) | JP4417007B2 (es) |
KR (1) | KR100603163B1 (es) |
CN (1) | CN1232508C (es) |
AT (1) | ATE300522T1 (es) |
AU (2) | AU2002229057B2 (es) |
BR (1) | BR0116229A (es) |
CA (1) | CA2427831C (es) |
CZ (1) | CZ20031379A3 (es) |
DE (1) | DE60112325T2 (es) |
DK (1) | DK1343766T3 (es) |
ES (1) | ES2247190T3 (es) |
HU (1) | HUP0303991A3 (es) |
IL (2) | IL155677A0 (es) |
MX (1) | MXPA03005338A (es) |
NO (1) | NO325236B1 (es) |
NZ (1) | NZ525569A (es) |
PL (1) | PL207394B1 (es) |
WO (1) | WO2002048113A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100735587B1 (ko) * | 2002-08-05 | 2007-07-04 | 더 프록터 앤드 갬블 캄파니 | 퀴놀론계 항생제 중간체의 제조 방법 |
US6803469B2 (en) * | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
EP4059923A1 (en) | 2002-11-20 | 2022-09-21 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
US7402674B2 (en) | 2004-01-31 | 2008-07-22 | Sanofi-Aventis Deutschland Gmbh, | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
WO2007102499A1 (ja) | 2006-03-06 | 2007-09-13 | Japan Tobacco Inc. | 4-オキソキノリン化合物の製造方法 |
AU2007223260C1 (en) | 2006-03-06 | 2011-02-03 | Japan Tobacco Inc. | Method for producing 4-oxoquinoline compound |
CN105315154A (zh) * | 2006-09-12 | 2016-02-10 | 吉里德科学公司 | 制备整合酶抑制剂的方法和中间体 |
US8658183B2 (en) | 2007-08-09 | 2014-02-25 | Taigen Biotechnology Company, Ltd. | Antimicrobial parenteral formulation |
AR068403A1 (es) * | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
US8211909B2 (en) | 2008-07-01 | 2012-07-03 | Taigen Biotechnology Co., Ltd. | Treatment of antibiotic-resistant bacteria infection |
SG11201500812QA (en) | 2012-08-03 | 2015-04-29 | Gilead Sciences Inc | Process and intermediates for preparing integrase inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ290722A (en) * | 1994-08-02 | 1999-03-29 | Procter & Gamble | A process for making derivatives of quinolonyl lactam (qla's); intermediates |
JPH10504815A (ja) * | 1994-08-02 | 1998-05-12 | ザ、プロクター、エンド、ギャンブル、カンパニー | 抗微生物化合物の製造方法 |
-
2001
- 2001-12-07 HU HU0303991A patent/HUP0303991A3/hu unknown
- 2001-12-07 ES ES01990192T patent/ES2247190T3/es not_active Expired - Lifetime
- 2001-12-07 AU AU2002229057A patent/AU2002229057B2/en not_active Ceased
- 2001-12-07 WO PCT/US2001/048536 patent/WO2002048113A1/en active IP Right Grant
- 2001-12-07 EP EP01990192A patent/EP1343766B1/en not_active Expired - Lifetime
- 2001-12-07 CZ CZ20031379A patent/CZ20031379A3/cs unknown
- 2001-12-07 DE DE60112325T patent/DE60112325T2/de not_active Expired - Lifetime
- 2001-12-07 CA CA002427831A patent/CA2427831C/en not_active Expired - Fee Related
- 2001-12-07 JP JP2002549644A patent/JP4417007B2/ja not_active Expired - Fee Related
- 2001-12-07 PL PL363355A patent/PL207394B1/pl not_active IP Right Cessation
- 2001-12-07 DK DK01990192T patent/DK1343766T3/da active
- 2001-12-07 AU AU2905702A patent/AU2905702A/xx active Pending
- 2001-12-07 CN CNB018207146A patent/CN1232508C/zh not_active Expired - Lifetime
- 2001-12-07 MX MXPA03005338A patent/MXPA03005338A/es active IP Right Grant
- 2001-12-07 KR KR1020037007905A patent/KR100603163B1/ko not_active IP Right Cessation
- 2001-12-07 IL IL15567701A patent/IL155677A0/xx active IP Right Grant
- 2001-12-07 NZ NZ525569A patent/NZ525569A/en not_active IP Right Cessation
- 2001-12-07 BR BR0116229-2A patent/BR0116229A/pt not_active IP Right Cessation
- 2001-12-07 AT AT01990192T patent/ATE300522T1/de active
-
2003
- 2003-04-30 IL IL155677A patent/IL155677A/en not_active IP Right Cessation
- 2003-06-12 NO NO20032667A patent/NO325236B1/no not_active IP Right Cessation
-
2009
- 2009-10-05 JP JP2009231801A patent/JP2010001315A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2905702A (en) | 2002-06-24 |
NO20032667D0 (no) | 2003-06-12 |
HUP0303991A3 (en) | 2012-09-28 |
NZ525569A (en) | 2004-09-24 |
BR0116229A (pt) | 2003-11-04 |
KR100603163B1 (ko) | 2006-07-24 |
ATE300522T1 (de) | 2005-08-15 |
HUP0303991A2 (hu) | 2004-04-28 |
NO325236B1 (no) | 2008-03-03 |
CZ20031379A3 (cs) | 2003-11-12 |
PL207394B1 (pl) | 2010-12-31 |
DE60112325D1 (de) | 2005-09-01 |
IL155677A0 (en) | 2003-11-23 |
EP1343766A1 (en) | 2003-09-17 |
EP1343766B1 (en) | 2005-07-27 |
PL363355A1 (en) | 2004-11-15 |
CA2427831A1 (en) | 2002-06-20 |
IL155677A (en) | 2009-02-11 |
MXPA03005338A (es) | 2003-10-06 |
AU2002229057B2 (en) | 2005-04-21 |
CN1481365A (zh) | 2004-03-10 |
CN1232508C (zh) | 2005-12-21 |
JP2004515542A (ja) | 2004-05-27 |
DE60112325T2 (de) | 2006-05-24 |
CA2427831C (en) | 2009-08-18 |
ES2247190T3 (es) | 2006-03-01 |
KR20030063420A (ko) | 2003-07-28 |
JP4417007B2 (ja) | 2010-02-17 |
NO20032667L (no) | 2003-08-14 |
JP2010001315A (ja) | 2010-01-07 |
WO2002048113A1 (en) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1070056E (pt) | Inibidores de pde iii/iv a base de ftalazinona | |
RS86804A (en) | Quinoline and isoquinoline derivatives method for the production thereof and use therof as anti-inflammatory agents | |
NO20024869D0 (no) | Oksygenatomdanningsprosess | |
DK1343766T3 (da) | Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner | |
ATE275554T1 (de) | Serinprotease-inhibitoren | |
TNSN05245A1 (en) | A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
EA200000975A1 (ru) | 6-(2-гало-4-алкоксифенил)триазолпиримидины с фунгицидным действием | |
DK1373255T3 (da) | Fremgangsmåde til fremstilling af imidazolforbindelser | |
DK1278757T3 (da) | Fremstilling af sekundære aminoisobutylalkoxysilaner | |
DK1206452T3 (da) | Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser | |
TR200402546T4 (tr) | Taksan türevleri hazırlamak için işlem. | |
DK1165485T3 (da) | Fremgangsmåde til fremstilling af pesticidmellemprodukter | |
DK1444236T3 (da) | Separation af regioisomere af metal-phthalocyaniner | |
DK1280752T3 (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-chlorphenoler | |
DK1272486T3 (da) | Fremgangsmåde til fremstilling af 7-(pyrazol-3-yl)benzoxazoler | |
SE0003186D0 (sv) | New process | |
ATE446952T1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
DK1250335T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner | |
DK1085019T3 (da) | Omoprazolsyntese | |
SE0101323D0 (sv) | New process | |
DK1320527T3 (da) | Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler | |
SE0000382D0 (sv) | New process | |
WO2003044877A3 (en) | Light emitting device and compounds for use therein | |
DE50203367D1 (de) | Verfahren zur herstellung von orthocarbonsäuretrialkylestern |